Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.8.3549

Primary Small Cell Carcinoma of the Urinary Bladder - Mini-review of the Literature  

Chhabra, Sarabjeet (Department of Urology, Kasturba Medical College)
Hegde, Padmaraj (Department of Urology, Kasturba Medical College)
Singhal, Paras (Department of Urology, Medanta- The Medicity Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.8, 2012 , pp. 3549-3553 More about this Journal
Abstract
Primary small cell carcinoma of urinary bladder is a rare but aggressive disease with poor prognosis and a high mortality rate. It accounts for less than 1 % of all the primary cancers seen in the urinary bladder. Diagnosis and management of this entity poses a challenge to the clinician due to the lack of a standardized protocol for its treatment. Herein we discuss primary small cell carcinoma of the urinary bladder in its entirety.
Keywords
Small cell carcinoma; urinary bladder; bladder tumor; etiology; diagnosis; treatment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pan CX, Yang XJ, Lopez-Beltran A, et al (2005). c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol, 18, 320-3.   DOI
2 Pan CX, Zhang H, Lara PN Jr, Cheng L (2006). Small-cell carcinoma of the urinary bladder: diagnosis and management. Expert Rev Anticancer Ther, 6, 1707-13.   DOI
3 Partanen S, Asikainen U (1985). Oat cell carcinoma of the urinary bladder with ectopic adrenocorticotropic hormone production. Hum Pathol, 16, 313-5.   DOI
4 Podesta AH, True LD (1989). Small cell carcinoma of the bladder. Report of five cases with immunohistochemistry and review of the literature with evaluation of prognosis according to stage. Cancer, 64, 710-4.   DOI
5 Puente S, Velasco A, Gallel P, et al (2008). Metastatic small cell carcinoma to the thyroid gland. A pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr Pathol, 19, 190-6.   DOI   ScienceOn
6 Quek ML, Nichols PW, Yamzon J, et al (2005). Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience. J Urol, 174, 93-6.   DOI
7 Reyes CV, Soneru I (1985). Small cell carcinoma of the urinary bladder with hypercalcemia. Cancer, 56, 2530-3.   DOI
8 Rollins S, Schumann GB (1991). Primary urinary cytodiagnosis of a bladder small-cell carcinoma. Diagn Cytopathol., 7, 79-82.   DOI
9 Sidhu GS (1979). The endodermal origin of digestive and respiratory tract APUD cells: histopatologic evidence and a revive of the literature. Am J Pathol, 96, 5-20.
10 Siefker-Radtke AO, Dinney CP, Abrahams NA, et al (2004). Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol, 172, 481-4.   DOI
11 Soriano P, Navarro S, Gil M, Llombart-Bosch A (2004). Smallcell carcinoma of the urinary bladder. A clinico-pathological study of ten cases. Virchows Arch, 445, 292-7.   DOI
12 Sved P, Gomez P, Manoharan Civantos MF, Soloway MS (2004). Small cell carcinoma of the bladder. BJU Int, 94, 12-7.   DOI
13 Syed ZA, Victor ER, Maureen FZ (1997). Small cell neuroendocrine carcinoma of the urinary bladder. Cancer, 79, 356-61.   DOI
14 Trias I, Algaba F, Condom E, et al (2001). Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol, 39, 85-90.   DOI
15 WHO Classification of the Tumours: Pathology and Genetics of Tumours of the Urinary System and Mal Genital Organs (2004). Edited by: Eble JN, Sauter G, Epstein J. IARC Press Lyon, France.
16 Angulo JC, Lopez JI, Sanchez-Chapado M, et al (1996). Small cell carcinoma of the urinary bladder. J Urol Pathol, 5, 1-19.
17 Abbas F, Civantos F, Benedetto P, Soloway MS (1995). Small cell carcinoma of the bladder and prostate. Urology, 46, 617-30.   DOI
18 Abenoza P, Manivel C, Sibley RK (1986). Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab, 110, 1062-6.
19 Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG (2005). Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Histopathology, 46, 57-63.   DOI
20 Ali SZ, Reuter VE, Zakowski MF (1997). Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer, 79, 356-61.   DOI
21 Bastus R, Caballero JM, Gonzalez G et al (1999). Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur Urol, 3, 323-6.
22 Bex A (2008). Review: Treatment of small cell carcinoma of the urinary bladder: Can we learn from small cell lung cancer? Clin Adv Hematol Oncol, 6, 385-6.
23 Bex A, Nieuwenhuijzen JA, Kerst M, et al (2005). Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology, 65, 295-9.   DOI
24 Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ (1989). Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer, 64, 1347-57.   DOI   ScienceOn
25 Cheng C, Nicholson A, Lowe DG, Kirby RS (1992). Oat cell carcinoma of the urinary bladder. Urology, 39, 504-7.   DOI
26 Cheng D, Unger P, Forscher CA, Fine E (1995). Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy. J Urol, 153, 417-9.   DOI
27 Christopher ME, Seftel AD, Sorenson K, Resnick MI (1991). Small cell carcinoma of the genitourinary tract: An immunohistochemical, electron microscopic and clinicopathological study. J Urol, 146, 382-8.   DOI
28 Cheng L, Jones TD, McCarthy RP, et al (2005). Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol, 166, 1533-9.   DOI
29 Cheng L, Pan CX, Yang XJ, et al (2004). Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer, 101, 957-62.   DOI
30 Choong NW, Quevedo JF, Kaur JS (2005). Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer, 103, 1172-8.   DOI
31 Cramer SF, Aikawa M, Cebelin M (1981). Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer, 47, 724-30.   DOI
32 Grignon DJ, Ro JY, Ayala AG, et al (1992). Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer, 69, 527-36.   DOI
33 Helpap B (2002). Morphologic and therapeutic strategies for neuroendocrine tumors of genitourinary tract. Cancer, 95, 1415-20.   DOI   ScienceOn
34 Hoeven KH, Artymyshyn RL (1996). Cytology of small cell carcinoma of the urinary bladder. Diag Cytopathol, 14, 292-7   DOI
35 Holmang S, Borghede G, Johansson SL (1995). Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol, 153, 1820-2.   DOI
36 Iczkowski KA, Shanks JH, Bostwick DG (1998). Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma. Histopathology, 32, 322-7.   DOI
37 Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL (2000). Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period. Scand. J Urol Nephrol, 34, 95-101.   DOI
38 Ibrahim NJ, Briggs JC, Corbishley CM (1984). Extrapulmonary oat cell carcinoma. Cancer, 54, 1645-61.   DOI   ScienceOn
39 Iczkowski KA, Shanks JH, Allsbrook WC, et al (1999). Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense g-enolase expression. Histopathology, 35, 150-6.   DOI
40 Ismaili N, Elkarak F, Heudel PE, Flechon A, Droz JP (2008). Small cell cancer of the bladder: The Leon-Berard cancer centre experience. Indian J Urol, 24, 494-7.   DOI
41 Ismaili N, Heudel PE, Elkarak F, et al (2009). Outcome of recurrent and metastatic small cell carcinoma of the bladder. BMC Urology, 9, 4.   DOI
42 Jackman DM, Johnson BE (2005). Small-cell lung cancer. Lancet, 366, 1385-96.   DOI   ScienceOn
43 Lester JF, Hudson E, Barber JB (2006). Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature. Clin Oncol, 18, 608-11   DOI
44 Lohrisch C, Murray N, Pickles T, Sullivan L (1999). Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer, 86, 2346-52.   DOI
45 Mills SE, Wolfe III JT, Weiss MA, et al (1987). Small cell undifferentiated carcinoma of the urinary bladder. A lightmicroscopic, immunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol, 11, 606-17.   DOI
46 Lopez JI, Angulo JC, Flores N, Toledo JD (1994). Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases. Br J Urol, 73, 43-9.   DOI
47 Mackey JR, Au HJ, Hugh J, Venner P (1998). Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol, 159, 1624-9.   DOI   ScienceOn
48 Mangar SA, Logue JP, Shanks JH, et al (2004). Small cell carcinoma of the urinary bladder: 10-year experience. Clin Oncol, 16, 523-7.   DOI
49 Murphy WM (1997). Diseases of the urinary bladder, urethra, ureters, and renal pelves. In: Murphy WM, ed. Urological Pathology. Philadelphia:Saunders, 98-111.
50 Nejat RJ, Purohit R, Goluboff ET, et al (2001). Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy. Urol Oncol, 6, 53-5.   DOI
51 Oblon DJ, Parsons JT, Zander DS, Wajsman Z (1993). Bladder preservation and durable complete remission of small cell carcinoma of the bladder with systemic chemotherapy and adjuvant radiation therapy. Cancer, 71, 2581-4.   DOI
52 Oesterling JE, Brendler CB, Burgers JK, Marshall FF, Epstein JI (1990). Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostarectomy and adjuvant methotrexate, vinblastine, doxorubicin and cisplatine chemotherapy. Cancer, 65, 1928-36.   DOI